Shanghai Pharmaceuticals Holding Co (HK:2607) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Shanghai Pharmaceuticals Holding Co., Ltd. has announced its unaudited interim financial results for the first half of 2024, revealing a consolidated net profit of RMB 2.94 billion. The company plans to reward shareholders with a cash dividend of RMB 0.80 per ten shares, which amounts to 10.07% of its net profit. The interim report, yet to be audited, confirms that there are no significant risks affecting the company’s operations during the reporting period.
For further insights into HK:2607 stock, check out TipRanks’ Stock Analysis page.
